Who are Hyperion Therapeutics's investors?

Hyperion Therapeutics's investors include Bay City Capital, Sofinnova Ventures, New Enterprise Associates (NEA).

How much funding has Hyperion Therapeutics raised?

Hyperion Therapeutics has disclosed $8M raised across 1 round.

Hyperion Therapeutics is headquartered in Brisbane, US.

Brisbane, US · 3 known investors

Addressing unmet needs in gastroenterology and hepatology. (NASDAQ: HPTX) (Acquired Horizon Therapeutics)

Christine NashExecutive

Natalie HollesinSVP, Corporate & Business Development2013–2015Director at Renasant Bio

Ashley GouldExecutive

Donald J. SantelExecutive

Klara A. DickinsonExecutive

Bruce F. ScharschmidtExecutive

Jeffrey S. FarrowExecutive

Jake R. Nunn inBoard Member2009–2015Partner at SR One Capital Management

Bijan Salehizadeh inBoard directorManaging Director at NaviMed Capital

Bo Jesper HansenBoard director

Daniel G. WelchBoard director

Lota S. ZothBoard director

Form D private placements

$8M disclosed across 1 round · 2014

▶$8MraisedJun 2014 · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

What does Hyperion Therapeutics do?: Addressing unmet needs in gastroenterology and hepatology. (NASDAQ: HPTX) (Acquired Horizon Therapeutics)
Who are Hyperion Therapeutics's investors?: Hyperion Therapeutics's investors include Bay City Capital, Sofinnova Ventures, New Enterprise Associates (NEA).
How much funding has Hyperion Therapeutics raised?: Hyperion Therapeutics has disclosed $8M raised across 1 round.
Where is Hyperion Therapeutics headquartered?: Hyperion Therapeutics is headquartered in Brisbane, US.